NCT02254551 2017-02-16Safety/Efficacy Study of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple MyelomaSCRI Development Innovations, LLCPhase 2 Terminated7 enrolled 6 charts